M1 Kliniken AG (ETR:M12)
Germany · Delayed Price · Currency is EUR 18.88
+0.22 (1.18%)
Aug 4, 2026, 5:35 PM CET
M1 Kliniken AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 365.47 | 340.41 | 317.99 | 286.77 | 315.49 | |
Revenue Growth | 7.36% | 7.05% | 10.89% | -9.10% | 96.88% |
Cost of Revenue | 311 | 295.48 | 283.45 | 253.46 | 281.43 |
Gross Profit | 54.47 | 44.94 | 34.54 | 33.32 | 34.06 |
Selling, General & Admin | 15.03 | 13.02 | 13.53 | 17.91 | 16.23 |
Depreciation & Amortization Expenses | 4.88 | 5.16 | 5.31 | 6.06 | 5.69 |
Total Operating Expenses | 19.91 | 18.18 | 18.84 | 23.97 | 21.92 |
Operating Income | 34.56 | 26.75 | 15.7 | 9.35 | 12.13 |
Interest Income | 1.04 | 0.99 | 2.1 | 1.5 | 1.21 |
Interest Expense | - | - | -0 | -0.83 | -0.92 |
Other Non-Operating Income (Expense) | -1.54 | -1.45 | -1.35 | 0.22 | 2 |
Total Non-Operating Income (Expense) | -0.5 | -0.46 | 0.74 | 0.89 | 2.29 |
Pretax Income | 39.44 | 31.91 | 16.45 | 15.41 | 14.42 |
Provision for Income Taxes | 9.96 | 8.51 | 4.78 | 3.16 | 3.54 |
Net Income | 24.1 | 17.79 | 11.67 | 7.07 | 10.88 |
Minority Interest in Earnings | 1.97 | 1.77 | 1.39 | 2.75 | 1.97 |
Net Income to Common | 22.13 | 16.02 | 10.27 | 4.32 | 8.91 |
Net Income Growth | 38.17% | 55.91% | 137.98% | -51.52% | 30.52% |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 |
Shares Change | - | - | - | - | 5.70% |
EPS (Basic) | 1.19 | 0.85 | 0.54 | 0.24 | 0.45 |
EPS (Diluted) | 1.19 | 0.85 | 0.54 | 0.24 | 0.45 |
EPS Growth | 40.00% | 57.41% | 125.00% | -46.67% | 21.62% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 37.63 | 30.32 | 7.35 | 19.61 | 14.66 |
Free Cash Flow Growth | 24.11% | 312.24% | -62.49% | 33.76% | 69.77% |
Free Cash Flow Per Share | 1.92 | 1.54 | 0.37 | 1.00 | 0.75 |
Dividends Per Share | 1.200 | 0.500 | 0.500 | - | - |
Dividend Growth | 140.00% | 0% | - | - | - |
Gross Margin | 14.91% | 13.20% | 10.86% | 11.62% | 10.79% |
Operating Margin | 9.46% | 7.86% | 4.94% | 3.26% | 3.85% |
Profit Margin | 6.59% | 5.23% | 3.67% | 2.47% | 3.45% |
FCF Margin | 10.30% | 8.91% | 2.31% | 6.84% | 4.65% |
EBITDA | 35.35 | 27.77 | 16.85 | 15.21 | 13.7 |
EBITDA Margin | 9.67% | 8.16% | 5.30% | 5.30% | 4.34% |
EBIT | 34.56 | 26.75 | 15.7 | 9.35 | 12.13 |
EBIT Margin | 9.46% | 7.86% | 4.94% | 3.26% | 3.85% |
Effective Tax Rate | 25.26% | 26.66% | 29.06% | 20.53% | 24.57% |